Debt-hobbled Glenmark is looking to boost earnings. Execution will be key to winning back investors.

Glenn Saldanha, managing director and CEO, Glenmark pharmaceuticals; image credit: Agencies Synopsis Coping with a tough US generics business and high R&D spends, Glenmark’s earnings growth has been muted. To realign with the changing business environment, the company has set new goals for the next four-five years, which includes doubling down on India, its stronghold.

Read More

Sun Pharma: Why Sun Pharma is shelling out USD576 million on a hair-loss drug to fire its specialty-drugs game

Sun Pharmaceutical Industries is scaling new heights. After a setback in the US generic-drugs business, India’s largest drugmaker has gradually moved up the value chain and built a sizeable specialty-drugs business over the last few years. Dilip Shanghvi, founder and managing director of Sun Pharma, with his astute sense of business and passion for science,

Read More

Rajendra Badwe: How Rajendra Badwe is making cancer treatment affordable by repurposing easily available drugs

Dr. Rajendra Achyut Badwe, Director, Tata Memorial Center. Synopsis Badwe, director of Mumbai’s Tata Memorial Centre, has reset the rules to revolutionise treatment standards. His views on disease management and research protocols count not just in India but also at world’s leading institutions. Last September, in one such instance, Badwe and his team of doctors

Read More

Carrying organs to blood samples, drones can change healthcare. But not before limitations are fixed.

Technicians fly a drone to deliver medical supplies during testing at Gauribidanur, near Banglore. Synopsis The use of drones in healthcare is in its test phase. There are already instances of medical drones transporting live organs for transplant, delivering vaccines in remote areas, or carrying oxygen cylinders. However, for medical drones to become mainstream, technical,

Read More

Why New Delhi needs to mount an India-driven global health-diplomacy push, and what it needs to do

Workers unload cartons of a Covid-19 coronavirus vaccine being delivered from India to Myanmar Synopsis The pandemic has catapulted India to the high table of global health diplomacy. Using its position as the world’s leading supplier of vaccines and medicines, it has wielded its soft power to great effect, grabbing significant political clout internationally. In

Read More